Table of Contents for Nuclear Cardiology Markets
Table of Contents:
1. Overview 5
1.1 Objectives 5
1.2 Scope 6
1.3 Methodology 6
1.4 Executive Summary 6
2. Medical Imaging Market Analysis 9
2.1 Medical Imaging Industry Market Size 9
2.2 Medical Imaging Infrastructure 10
2.2.1 Total Healthcare Expenditures and Demographics 10
2.2.2 Number of Hospitals 11
2.2.3 Number of Radiologists 12
2.2.4 Radiology Services 13
2.2.5 Medical Imaging Companies 15
2.2.6 Market Drivers 15
2.2.6.1 Product Enhancements 16
2.2.6.2 Contrast Agents Development 16
2.2.6.3 Innovation 16
2.2.7 Market Restraints 17
2.2.8 Market Segments for Medical Imaging 17
2.2.8.1 Discovery 17
2.2.8.2 Clinical Applications 18
2.2.8.3 Clinical Trials 18
2.2.8.4 Outpatient Facilities 18
2.2.8.5 Technology Advances in Diagnostic Imaging Modalities 18
2.2.8.6 Safety and Ergonomics Concerns 18
2.2.8.7 Volumetric Imaging 19
2.2.8.8 Digital Radiography (DR) 19
2.2.8.9 Contrast Media 20
3. Nuclear Medicine and Nuclear Cardiology Market 28
3.1 Medical Imaging Industry Forecasts 28
3.2 Hardware Companies (Nuclear Medicine Instrumentation) 29
3.3 Software Companies (Image Processing and PACS) 29
3.4 Radiopharmaceuticals and Pharmaceuticals Companies 30
3.5 Ancillary Products Companies 30
3.6 Service and Support Companies 30
3.7 Nuclear Cardiology Market 30
3.8 Hardware (PET, SPECT and Hybrids) 32
3.8.1 Scanner Investment: Not Just a Cardiology Market 32
3.8.1.1 Impact of Alzheimer's Reimbursement 33
3.8.2 Sales Trends for PET Scanners 33
3.8.3 Market Consolidation in the U.S. 33
3.8.4 Learning Curve Impact for PET 34
3.8.5 Hardware Market Trends 34
3.9 Software (PACS and RIS) 35
3.10 Radiopharmaceuticals 36
3.10.1 Diagnostic Radiopharmaceuticals 36
3.10.2 Therapeutic Radiopharmaceuticals 36
4. Products Analysis 37
4.1 Nuclear Medicine Instrumentation 37
4.1.1 PET Scan 37
4.1.2 SPECT Scan 38
4.1.2.1 Heart Imaging 40
4.1.3 PET Versus SPECT 41
4.1.4 Hybrid Technology 41
4.2 Image Processing: PACS 45
4.2.1 Making PACS Work with Nuclear Medicine 45
4.2.1.1 Failure to Communicate 45
4.2.1.2 3-D and Quantitative Analysis 46
4.2.1.3 Yale's PACS Makeover 46
4.2.1.4 Color Issues 47
4.2.1.5 Small Market Opportunities 47
4.2.1.6 Looking Ahead 47
4.3 Radiopharmaceuticals and Pharmaceuticals 48
4.3.1 Introduction 48
4.3.2 Background 48
4.3.3 Areas of Current Interest 49
5. Regulations, Reimbursements and Other Issues 51
5.1 Food and Drug Administration (FDA) 51
5.1.1 FDA Guidance 51
5.1.2 FDA Nuclear Medicine Coalition 51
5.2 U.S. Nuclear Regulatory Commission (NRC) 51
5.2.1 What NRC Regulates 51
5.2.2 How NRC Regulates 52
5.2.3 Related Information 52
5.3 Memorandum of Understanding between NRC and FDA 52
5.3.1 Authorities and Regulatory Programs 52
5.4 Current NRC Issues and Actions 55
5.4.1 Meetings 55
5.4.2 Program and Policy Issues 55
5.4.3 Recently Issued Significant Enforcement Actions 56
5.4.3.1 Stark II Regulations 56
5.4.3.2 Recent Impact of Stark II Regulations 57
5.4.3.3 Reimbursement 57
6. Business Affairs (Mergers, Acquisitions and Partnerships) 58
6.1 Recent Corporate Partnerships and Mergers 58
6.2 Recent Industry Activity 58
6.3 Product Launches and Developments 59
7. Technology Trends 61
7.1 Hardware (Nuclear Medicine Instrumentation) 61
7.2 Software (PACS) 64
7.2.1 Problems Interfacing PACS and NM 65
7.2.2 SNM and IHE 65
7.2.3 IHE Nuclear Medicine Profile 65
7.2.4 What Next? 66
7.2.5 Optimal Patient Care 67
7.2.6 Four Steps to Standards Adoption 67
7.2.7 Technical Framework: Business with Technology 68
7.2.8 Leading by Example 69
7.2.9 IHE and Electronic Health Record (EHR) 69
7.3 Radiopharmaceuticals and Pharmaceuticals 69
7.3.1 Market Share 70
7.3.2 Contrast Media Market Drivers 71
7.3.3 Contrast Media Market Sector Overview 71
7.3.4 Contrast Media Market Analysis 72
7.3.5 Growth Prospects for Contrast Media 72
7.4 Market Sector Analysis 72
7.5 Leading Companies in General Medical Imaging 74
8. Company Profiles 75
8.1 Hardware (Nuclear Medicine Instrumentation) 75
8.1.1 AccuSync Medical Research 75
8.1.2 Bristol-Myers Squibb (Medical Imaging) 75
8.1.3 Capintec 76
8.1.4 CardiArc 76
8.1.5 Cardinal Health (Cardiology Solutions) 76
8.1.6 Digirad 77
8.1.7 GE Healthcare 77
8.1.8 GVI Medical Devices 78
8.1.9 Hitachi Medical Systems America 79
8.1.10 IS2 Medical Systems 80
8.1.11 Mediso 80
8.1.12 Philips Medical 81
8.1.13 Positron 82
8.1.14 Siemens Medical 82
8.1.15 Spectrum Dynamics 83
8.2 Software (Image Processing and PACS) 84
8.2.1 Heartlab 84
8.2.2 Hermes Medical Solutions 85
8.2.3 INVIA 85
8.2.4 McKesson 86
8.2.5 MedImage 86
8.2.6 MIMvista 86
8.2.7 Numa 87
8.2.8 ProSolv Cardiovascular 87
8.2.9 Scientific Imaging 87
8.2.10 Segami Corporation 87
8.2.11 Syntermed 87
8.2.12 Thinking Systems Corporation 88
8.2.13 UltraSPECT 88
8.2.14 Witt Biomedical Corporation 88
8.3 Radiopharmaceuticals and Pharmaceuticals 88
8.3.1 Astellas Pharma U.S. 88
8.3.2 Bracco Diagnostics 89
8.3.3 Isotope Products Laboratories 89
8.3.4 Izotop: Institute of Isotopes 90
8.3.5 Mallinckrodt 90
8.3.6 Merck 90
8.3.7 NuView Radiopharmaceuticals 92
8.3.8 Pfizer 92
8.3.9 Tyco Healthcare 92
8.4 Ancillary Products 93
8.4.1 CNMTStore.com 93
8.4.2 Data Spectrum Corporation 93
8.4.3 Daxor Corporation 94
8.4.4 Ivy Biomedical Systems 94
8.4.5 MarCal Medical 94
8.5 Service and Support 94
8.5.1 BC Technical 94
8.5.2 Diagnostix Plus 95
8.5.3 MedAxiom 95
8.5.4 MediNuclear Corporation (MNC) 95
8.5.5 MEDX 95
8.5.6 Pinestar Technology 96
8.5.7 Technology Imaging Services 96
8.6 Other Business Opportunities 96
9. Other Elements of Nuclear Medicine Industry 97
9.1 Nuclear Medicine: Guidelines, Certification and Societies 97
9.1.1 American College of Radiology (ACR) 97
9.1.2 American Society of Nuclear Cardiology (ASNC) 97
9.1.3 Associates in Medical Physics (AMP) 97
9.1.4 Certification Board of Nuclear Cardiology (CBNC) 97
9.1.5 ICANL 98
9.1.6 IHE 98
9.1.7 ISO 98
9.1.8 MedPage Today 98
9.1.9 Nuclear Medicine Technology Certification Board (NMTCB) 98
9.1.10 Society of Cardiovascular Computed Tomography (SCCT) 99
9.1.11 Society of Nuclear Medicine (SNM) 99
9.2 Nuclear Medicine: Publications 99
9.2.1 Elsevier 99
9.2.2 HRA Research 100
9.2.3 Lippincott Williams & Wilkins 100
INDEX OF FIGURES
Figure 3.1: U.S. Nuclear Imaging Procedures 31
Figure 3.2: Digirad--Growth of Nuclear Imaging Procedures, 2004-2006 31
Figure 4.1: Nuclear Imaging 37
Figure 4.2: PET Scan 38
Figure 4.3: SPECT Scan 39
Figure 4.4: PET-CT Scan 42
Figure 4.5: SPECT-CT Scan 44
Figure 7.1: IHE Technical Framework 67
Figure 7.2: IHE Framework Organization 68
Figure 7.3: IHE Actors and Transactions 69
INDEX OF TABLES
Table 2.1: U.S. Medical Imaging Market Size, 2001-2010 9
Table 2.2: Global Medical Imaging Market Size, 2001-2010 9
Table 2.3: U.S. Health Expenditures as a Percentage of GDP, 2000-2010 10
Table 2.4: U.S. User Expenditures for Medical Imaging Equipment and Related Products 10
Table 2.5: Millions of Americans Over 65 Years of Age, 2000-2050 11
Table 2.6: Hospital Survey 11
Table 2.7: Percent Change in Volume of Examinations per Imaging Modality, 1993-2004 14
Table 2.8: Worldwide Market Share of Medical Imaging Companies 15
Table 2.9: Worldwide Imaging Procedures, 2001 to 2010 21
Table 2.10: Data Sources for Nuclear Medicine Professionals and Facilities 26
Table 7.1: Market Share of Contrast Media Players 70
Table 7.2: Contrast Media Market Growth, 2003-2010 71
Table 7.3: Worldwide Imaging Procedures, 2001-2010 73
Table 8.1: Astellas Alliances 89
CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel: +44 (0)1494 771734
Fax: +44 (0)1494 778994
e-mail: keithw@cmsinfo.com
copyright © 2005 all rights reserved
For more information about us, visit CMSinfo.
